
The pharmaceutical industry is expected to expand due to increased chronic diseases and an aging population. Therefore, fundamentally strong pharma stocks Ipsen S.A. (IPSEY) and Collegium Pharmaceutical, Inc. (COLL) could be wise additions to your portfolio now. However, SNDL Inc. (SNDL) might be best avoided, given its weak fundamentals.
The global pharmaceutical market is expected to reach $1.48 trillion by 2028, exhibiting a CAGR of 5.8%. The industry’s largest segment is oncology drugs, with a projected market volume of $188.20 billion in 2023.